Locations
Durham, NC, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Seed
founded in
2018
In Soma Bio develops bio-inspired solutions for reconstructive plastic surgery, utilizing genetically engineered protein-based materials that mimic human tissue. Their flagship product, Fractomer, allows surgeons to use a patient’s own tissue instead of synthetic implants, enhancing safety and effectiveness in procedures like breast and facial reconstruction. Founded by a team of experienced biomedical engineers and clinicians, the company is positioned to disrupt the reconstructive surgery market with innovative, natural solutions that improve patient outcomes. With a strong focus on regulatory compliance and clinical evaluation, in Soma Bio is poised for significant growth in the regenerative medicine space.
Something looks off?On-site & Remote